CA9 抗体
(Carbonic Anhydrase IX (CA9))
Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA IX is a transmembrane protein and the only tumor-associated carbonic anhydrase isoenzyme known. It is expressed in all clear-cell renal cell carcinoma, but is not detected in normal kidney or most other normal tissues. It may be involved in cell proliferation and transformation. This gene was mapped to 17q21.2 by fluorescence in situ hybridization, however, radiation hybrid mapping localized it to 9p13-p12. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| CA9 抗体 (AA 37-186) | 人 | 小鼠 Monoclonal |
|
|
|
| CA9 抗体 (AA 37-186) | 人 | 小鼠 Monoclonal |
|
|
|
| CA9 抗体 (AA 59-414) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant CA9 抗体 | 人 | 兔 Monoclonal |
|
|
|
| CA9 抗体 (AA 113-143) | 人 | 兔 Polyclonal |
|
|
|
| CA9 抗体 (AA 52-151) | 人 | 兔 Polyclonal |
|
|
|
| CA9 抗体 (AA 146-414) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| CA9 抗体 (AA 251-350) | 人 | 兔 Polyclonal |
|
|
|
| CA9 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| CA9 抗体 | 人, 马 | 小鼠 Monoclonal |
|
|
|
| CA9 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| CA9 抗体 (AA 113-143) | 人 | 兔 Polyclonal |
|
|
|
| CA9 抗体 | 人, 马 | 小鼠 Monoclonal |
|
|
|
| Recombinant CA9 抗体 | 人, 马 | 兔 Monoclonal |
|
|
|
| CA9 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| CA9 抗体 (AA 38-414) | 人 | 兔 Polyclonal |
|
|
|
| CA9 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant CA9 抗体 | 人 | 兔 Monoclonal |
|
|
|
| CA9 抗体 | 人 | 兔 Polyclonal |
|
|
|
| CA9 抗体 (AA 1-459) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 有验证图片)
2 references - 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 7C4A5
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 37-186
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 10F7A8
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 37-186
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 59-414
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- 质量等级
- KD Validated
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 23GB1770
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB18383
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 113-143
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 52-151
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 146-414
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 251-350
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 113-143
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- SDS (SDS-PAGE: 有验证图片)
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 马
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- PN-15
- 标记
- unconjugated
- 抗体亚型
- IgG2b, kappa
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- SDS (SDS-PAGE: 有验证图片)
- 适用
- 人, 马
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- CA9-2993R
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB8628
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 63-90, N-Term
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 38-414
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 4F12
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-459
Latest Publications for our CA9 抗体
: "Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8+ T-cell Responses." in: Molecular cancer therapeutics, Vol. 18, Issue 2, pp. 323-334, (2019) (PubMed).
: "Hypoxia-related carbonic anhydrase IX expression is associated with unfavourable response to first-line therapy in classical Hodgkin's lymphoma." in: Histopathology, Vol. 74, Issue 5, pp. 699-708, (2019) (PubMed).
: "ONECUT2 is a driver of neuroendocrine prostate cancer. ..." in: Nature communications, Vol. 10, Issue 1, pp. 278, (2019) (PubMed).
: "Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels." in: BMC cancer, Vol. 19, Issue 1, pp. 307, (2019) (PubMed).
: "Poor outcome in hypoxic endometrial carcinoma is related to vascular density. ..." in: British journal of cancer, Vol. 120, Issue 11, pp. 1037-1044, (2019) (PubMed).
: "Quaking orchestrates a post-transcriptional regulatory network of endothelial cell cycle progression critical to angiogenesis and metastasis." in: Oncogene, Vol. 38, Issue 26, pp. 5191-5210, (2019) (PubMed).
: "RNA-seq analysis of PHD and VHL inhibitors reveals differences and similarities to the hypoxia response." in: Wellcome open research, Vol. 4, pp. 17, (2019) (PubMed).
: "Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma." in: JCI insight, Vol. 4, Issue 5, (2019) (PubMed).
: "Volumetric Optoacoustic Imaging Unveils High-Resolution Patterns of Acute and Cyclic Hypoxia in a Murine Model of Breast Cancer." in: Cancer research, (2019) (PubMed).
: "Optimization of Window Study Endpoints in Endometrial Cancer." in: Frontiers in oncology, Vol. 9, pp. 428, (2019) (PubMed).
: "Hypoxia-related carbonic anhydrase IX expression is associated with unfavourable response to first-line therapy in classical Hodgkin's lymphoma." in: Histopathology, Vol. 74, Issue 5, pp. 699-708, (2019) (PubMed).
: "ONECUT2 is a driver of neuroendocrine prostate cancer. ..." in: Nature communications, Vol. 10, Issue 1, pp. 278, (2019) (PubMed).
: "Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels." in: BMC cancer, Vol. 19, Issue 1, pp. 307, (2019) (PubMed).
: "Poor outcome in hypoxic endometrial carcinoma is related to vascular density. ..." in: British journal of cancer, Vol. 120, Issue 11, pp. 1037-1044, (2019) (PubMed).
: "Quaking orchestrates a post-transcriptional regulatory network of endothelial cell cycle progression critical to angiogenesis and metastasis." in: Oncogene, Vol. 38, Issue 26, pp. 5191-5210, (2019) (PubMed).
: "RNA-seq analysis of PHD and VHL inhibitors reveals differences and similarities to the hypoxia response." in: Wellcome open research, Vol. 4, pp. 17, (2019) (PubMed).
: "Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma." in: JCI insight, Vol. 4, Issue 5, (2019) (PubMed).
: "Volumetric Optoacoustic Imaging Unveils High-Resolution Patterns of Acute and Cyclic Hypoxia in a Murine Model of Breast Cancer." in: Cancer research, (2019) (PubMed).
: "Optimization of Window Study Endpoints in Endometrial Cancer." in: Frontiers in oncology, Vol. 9, pp. 428, (2019) (PubMed).
Aliases for CA9 抗体
carbonic anhydrase 9 (CA9) 抗体carbonic anhydrase 9 (CAH9) 抗体
carbonic anhydrase 9 (Car9) 抗体
CA9 抗体
Ca9 抗体
CAIX 抗体
MN 抗体
MN/CA9 抗体
您还需要查找其他产品吗？
You are here:
